Qingguo Xu

Dr. Qingguo Xu

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
JSJung Soo Suk
Jung Soo Suk
Qingguo XuQingguo Xu
Qingguo Xu
NKNamho Kim
Namho Kim
JHJustin Hanes
Justin Hanes
LELaura M. Ensign
Laura M. Ensign

29 August 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ENElizabeth A. Nance
Elizabeth A. Nance
GWGraeme F. Woodworth
Graeme F. Woodworth
KSKurt A. Sailor
Kurt A. Sailor
TSTing-Yu Shih
Ting-Yu Shih
Qingguo XuQingguo Xu
Qingguo Xu
JHJustin Hanes
Justin Hanes
Nanoparticles densely coated with poly(ethylene glycol) rapidly penetrate within mouse, rat, and human brain parenchyma.

24 August 2015 in ACS Nano
Verified
Journal Article
Closed access
Qingguo XuQingguo Xu
Qingguo Xu
LELaura M. Ensign
Laura M. Ensign
NBNicholas J. Boylan
Nicholas J. Boylan
ASArne Schön
Arne Schön
XGXiaoqun Gong
Xiaoqun Gong
JHJustin Hanes
Justin Hanes

1 April 2013 in Journal of Controlled Release
Verified
Journal Article
Closed access
Qingguo XuQingguo Xu
Qingguo Xu
NBNicholas J. Boylan
Nicholas J. Boylan
JSJung Soo Suk
Jung Soo Suk
YWYing-Ying Wang
Ying-Ying Wang
ENElizabeth A. Nance
Elizabeth A. Nance
JHJustin Hanes
Justin Hanes

7 April 2017 in Science Advances
Verified
Journal Article
Open access
PDF file
CSCraig S. Schneider
Craig S. Schneider
Qingguo XuQingguo Xu
Qingguo Xu
NBNicholas J. Boylan
Nicholas J. Boylan
JCJane Chisholm
Jane Chisholm
BTBenjamin C. Tang
Benjamin C. Tang
JHJustin Hanes
Justin Hanes
Debunking the mucoadhesion myth: Nonsticky particles for enhanced pulmonary drug delivery.

24 August 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AEAmira Elgogary
Amira Elgogary
Qingguo XuQingguo Xu
Qingguo Xu
BPBrad Poore
Brad Poore
JAJesse Alt
Jesse Alt
SZSarah C. Zimmermann
Sarah C. Zimmermann
ALAnne Le
Anne Le
Significance: There are no effective therapies currently available for advanced pancreatic cancer. We show that there are two populations of cancer cells within a pancreatic tumor that require targeting by different metabolic inhibitors for effective tumor control. Rapidly dividing cells use glutamine, and can be effectively killed by administration of a nanoparticle containing an inhibitor of glutamine metabolism. Hypoxic cells, which are slowly dividing cells, metabolize glucose and can be targeted by metformin, a drug used for the treatment of diabetes. Clinical trials are needed to determine whether combination therapy, with drugs that effectively block the metabolism of glutamine and glucose, improves the survival of patients with pancreatic cancer.